Canine Atopic Dermatitis Global Market Report 2025
상품코드:1810847
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
개 아토피 피부염 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 10.3%로 40억 9,000만 달러로 성장할 것입니다. 예측 기간 동안의 성장은 수의학 분야에서의 원격의료 도입 증가, 맞춤형 반려동물 치료에 대한 수요 증가, 수의학 연구개발에 대한 투자 증가, 반려동물의 인간화 추세 확대, 수의학 진단에서 인공지능의 사용 증가 등에 기인할 것으로 보입니다. 예측 기간 동안 예상되는 주요 동향으로는 단클론항체 치료의 발전, 진단 도구에 대한 인공지능의 적용, 피부과 의료에 대한 원격의료의 통합, 증상 추적을 위한 웨어러블 기기의 사용, 알레르겐 특이적 면역 치료의 발전, 치료 모니터링을 위한 모바일 애플리케이션 개발 등이 있습니다.
개 피부 알레르기 환자 수의 증가는 개 아토피 피부염 시장 확대를 견인할 것으로 예상됩니다. 개의 피부 알레르기는 꽃가루, 특정 음식, 벼룩 물림 등의 알레르겐에 대해 면역체계가 과도하게 반응하여 가려움증, 발적, 염증 등의 증상을 유발합니다. 알레르기의 증가는 환경오염물질과 알레르겐에 노출될 기회가 많아진 것도 한 원인이며, 이러한 물질들이 면역반응을 강화시켜 피부의 불편함을 유발합니다. 개 아토피 피부염 치료는 염증과 가려움증을 최소화하고 2차 감염을 예방함으로써 이러한 문제를 완화하고 개 피부의 건강과 편안함을 개선합니다. 예를 들어, 2024년 1월 미국 정부 기관인 국립보건원(NIH)은 7,915명의 보호자(28.7%)가 반려견이 피부 관련 증상을 경험했다고 응답했다고 보고했습니다. 이 데이터에 따르면, 연령에 따라 피부 트러블이 확실히 증가하고 있으며, 강아지의 7%에서 노령견의 경우 37%에 달합니다. 이러한 유병률의 증가는 개 아토피 피부염 시장의 성장에 기여하고 있습니다.
반려동물 양육의 증가도 개 아토피 피부염 시장 성장에 기여하고 있습니다. 반려동물을 기르는 것은 가정에서 개나 고양이와 같은 가축을 돌보는 것을 포함합니다. 이러한 트렌드의 주요 원동력은 반려동물의 인간화가 진행되면서 동물을 가족의 일원으로, 정신적 지지와 동반자로 여기게 된 것이 주요 요인입니다. 개 아토피 피부염에 대응하는 것은 만성 가려움증과 염증을 완화하고 피부 건강을 개선하며 전반적인 편안함과 행복감을 높여 반려동물의 삶을 개선하는 데 필수적인 역할을 합니다. 예를 들어, 2025년 4월 미국의 산업 단체인 미국 반려동물용품협회(APPA)는 미국의 9,400만 가구(71%)가 반려동물을 키우고 있으며, 이는 2023-2024년 8,690만 가구(66%)에서 증가한 수치라고 보고했습니다. 그 결과, 반려동물 사육의 증가는 개 아토피 피부염 시장의 수요를 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 개 아토피 피부염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 개 아토피 피부염 시장 : 성장률 분석
세계의 개 아토피 피부염 시장 실적 : 규모와 성장, 2019-2024
세계의 개 아토피 피부염 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 개 아토피 피부염 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 개 아토피 피부염 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
글루코코르티코이드
항히스타민제
면역억제제
단클론항체(mAbs)
기타 제품
세계의 개 아토피 피부염 시장 : 견종별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
저먼셰퍼드
테리아
리트리버
기타 견종
세계의 개 아토피 피부염 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
외부기생충
식품 알레르기
알레르기성 피부 감염증
기타 적응증
세계의 개 아토피 피부염 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
토픽
주사제
세계의 개 아토피 피부염 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
수의 클리닉
소매 약국
온라인 약국
기타 유통 채널
세계의 개 아토피 피부염 시장 : 하위 세분화 글루코코르티코이드(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Prednisone
Prednisolone
Dexamethasone
Methylprednisolone
Hydrocortisone
Triamcinolone
세계의 개 아토피 피부염 시장 : 하위 세분화 항히스타민제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Diphenhydramine
Hydroxyzine
Cetirizine
Loratadine
Chlorpheniramine
세계의 개 아토피 피부염 시장 : 하위 세분화 면역억제제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Cyclosporine
Tacrolimus
Azathioprine
Mycophenolate Mofetil
세계의 개 아토피 피부염 시장 : 하위 세분화 단클론항체(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
Lokivetmab
임상시험용 단클론항체
세계의 개 아토피 피부염 시장 : 하위 세분화 기타 제품(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
필수지방산 보충제
약용 샴푸와 스프레이
알레르겐 특이적 면역요법(ASIT)
스킨 배리어 수복 크림
식이보충제와 프로바이오틱스
제7장 지역별·국가별 분석
세계의 개 아토피 피부염 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 개 아토피 피부염 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
개 아토피 피부염 시장 : 경쟁 구도
개 아토피 피부염 시장 : 기업 개요
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
Hill's Pet Nutrition Inc. Overview, Products and Services, Strategy and Financial Analysis
IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
Royal Canin SAS Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Ceva Sante Animale S.A.
Boragen
Virbac S.A.
Elanco Animal Health Inc.
Dechra Pharmaceuticals PLC
Antech Diagnostics Inc.
Vetoquinol S.A.
Heska Corporation
Bioiberica S.A.U.
Bimeda Animal Health Limited
Animal Dermatology Group Inc.
Kindred Biosciences Inc.
Bioceltix S.A.
Nextmune AB
OKAVA Pharmaceuticals Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
개 아토피 피부염 시장 2029 : 새로운 기회를 제공하는 국가
개 아토피 피부염 시장 2029 : 새로운 기회를 제공하는 부문
개 아토피 피부염 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Canine atopic dermatitis is a long-term, inflammatory skin disorder in dogs triggered by allergic reactions to environmental allergens like pollen, dust mites, mold, or certain foods. It is a hereditary condition that results in severe itching, skin redness, and frequent skin infections. The main goal of treating canine atopic dermatitis is to alleviate itching, decrease inflammation, and control secondary infections to enhance the dog's overall well-being.
The primary product categories used in the management of canine atopic dermatitis include glucocorticoids, antihistamines, immunosuppressants, monoclonal antibodies (mAbs), and other related therapies. Glucocorticoids are synthetic, broad-acting hormones that effectively relieve itching and inflammation by suppressing the immune response. This condition affects a variety of dog breeds, including German Shepherds, Terriers, Retrievers, and others, with common indications such as ectoparasites, food allergies, and allergic skin infections. Treatment methods include oral, topical, and injectable routes, and these products are distributed through veterinary clinics, retail pharmacies, online pharmacies, and other distribution channels.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care equipment. Higher duties on imported veterinary drugs, diagnostic tools, surgical instruments, and pet care products have increased operational costs for veterinary clinics, animal hospitals, and livestock care providers, forcing them to raise service fees or absorb shrinking margins. Livestock and agricultural sectors face similar challenges, with tariffs on feed additives, vaccines, and breeding equipment driving up production costs and affecting animal health management. Additionally, retaliatory tariffs in key export markets have reduced demand for U.S.-produced veterinary products, further straining industry revenues. The sector must now prioritize local sourcing, preventive care solutions, and digital health innovations to mitigate rising costs while maintaining high standards of animal care.
The canine atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides canine atopic dermatitis market statistics, including canine atopic dermatitis industry global market size, regional shares, competitors with a canine atopic dermatitis market share, detailed canine atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the canine atopic dermatitis industry. The canine atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The canine atopic dermatitis market size has grown rapidly in recent years. It will grow from $2.49 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to a rise in pet ownership, increased awareness of pet health, a growing incidence of allergic conditions in dogs, higher spending on veterinary healthcare, and the expanding availability of pet insurance.
The canine atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $4.09 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth during the forecast period can be attributed to the increasing adoption of telemedicine in veterinary care, rising demand for personalized pet treatments, growing investments in veterinary research and development, the expanding trend of pet humanization, and the increased use of artificial intelligence in veterinary diagnostics. Key trends expected in the forecast period include advancements in monoclonal antibody therapies, the application of artificial intelligence in diagnostic tools, integration of telemedicine for dermatological care, the use of wearable devices for tracking symptoms, progress in allergen-specific immunotherapy, and the development of mobile applications for monitoring treatment.
The growing number of skin allergy cases in dogs is expected to drive the expansion of the canine atopic dermatitis market. Skin allergies in dogs occur when their immune system overreacts to allergens like pollen, certain foods, or flea bites, leading to symptoms such as itching, redness, and irritation. This increase is partly due to greater exposure to environmental pollutants and allergens, which can trigger intensified immune responses and cause skin discomfort. Treatments for canine atopic dermatitis help alleviate these issues by minimizing inflammation and itching, as well as preventing secondary infections, thereby improving dogs' skin health and comfort. For example, in January 2024, the National Institutes of Health (NIH), a US-based government agency, reported that 7,915 dog owners (28.7%) indicated their dogs had experienced skin-related conditions. The data showed a steady increase in skin issues with age, from 7% in puppies to 37% in senior dogs. This rising prevalence is contributing to the growth of the canine atopic dermatitis market.
The increase in pet ownership is also contributing to the growth of the canine atopic dermatitis market. Pet ownership involves caring for domesticated animals, such as dogs, cats, and other companions, within a household setting. A key driver of this trend is the growing humanization of pets, where animals are increasingly seen as family members and sources of emotional support and companionship. Addressing canine atopic dermatitis plays an essential role in improving pets' lives by easing chronic itching and inflammation, enhancing skin health, and boosting overall comfort and well-being. For instance, in April 2025, the American Pet Products Association (APPA), a US-based trade association, reported that 94 million US households (71%) owned a pet, up from 86.9 million households (66%) in 2023-2024. As a result, the increase in pet ownership is fueling demand in the canine atopic dermatitis market.
Leading companies in the canine atopic dermatitis market are pursuing regulatory approvals to expand the global reach and availability of their treatments. Regulatory approvals are formal authorizations granted by health authorities after verifying that medical products meet safety, efficacy, and quality standards through comprehensive testing. For example, in September 2024, Elanco Animal Health Inc., a US-based pharmaceutical company focused on animal health, received US FDA approval for Zenrelia, a once-daily oral JAK inhibitor designed to treat allergic and atopic dermatitis in dogs. Zenrelia represents a significant innovation by addressing chronic, acute, or seasonal itching and inflammation with a single daily tablet. It functions by targeting the source of the itch and blocking the signaling pathways responsible for allergic reactions, thereby breaking the itch-scratch cycle. The treatment provides noticeable improvement from the first dose and helps minimize rebound itching, which is a common drawback in dogs treated with competing JAK inhibitors.
Major players in the canine atopic dermatitis market are Merck & Co. Inc., Zoetis Inc., Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Royal Canin SAS, Ceva Sante Animale S.A., Boragen, Virbac S.A., Elanco Animal Health Inc., Dechra Pharmaceuticals PLC, Antech Diagnostics Inc., Vetoquinol S.A., Heska Corporation, Bioiberica S.A.U., Bimeda Animal Health Limited, Animal Dermatology Group Inc., Kindred Biosciences Inc., Bioceltix S.A., Nextmune AB, OKAVA Pharmaceuticals Inc.
North America was the largest region in the canine atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in canine atopic dermatitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the canine atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The canine atopic dermatitis market consists of sales of products including medicated shampoos, hypoallergenic diets, omega-3 fatty acid supplements, skin barrier repair creams, and topical antimicrobial or antifungal treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Canine Atopic Dermatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on canine atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for canine atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The canine atopic dermatitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Glucocorticoids; Antihistamines; Immunosuppressants; Monoclonal Antibodies (mAbs); Other Products
2) By Dog Breed: German Shepherd; Terriers; Retrievers; Other Dog Breeds
3) By Indication: Ectoparasites; Food Allergy; Allergic Skin Infections; Other Indications
4) By Route Of Administration: Oral; Topical; Injectable
5) By Distribution Channel: Veterinary Clinics; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Glucocorticoids: Prednisone; Prednisolone; Dexamethasone; Methylprednisolone; Hydrocortisone; Triamcinolone
2) By Antihistamines: Diphenhydramine; Hydroxyzine; Cetirizine; Loratadine; Chlorpheniramine
3) By Immunosuppressants: Cyclosporine; Tacrolimus; Azathioprine; Mycophenolate Mofetil
4) By Monoclonal Antibodies: Lokivetmab; Investigational Monoclonal Antibodies
5) By Other Products: Essential Fatty Acid Supplements; Medicated Shampoos And Sprays; Allergen-Specific Immunotherapy (ASIT); Skin Barrier Repair Creams; Nutraceuticals And Probiotics
3. Canine Atopic Dermatitis Market Trends And Strategies
4. Canine Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Canine Atopic Dermatitis Growth Analysis And Strategic Analysis Framework
5.1. Global Canine Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Canine Atopic Dermatitis Market Growth Rate Analysis
5.4. Global Canine Atopic Dermatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Canine Atopic Dermatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Canine Atopic Dermatitis Total Addressable Market (TAM)
6. Canine Atopic Dermatitis Market Segmentation
6.1. Global Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Glucocorticoids
Antihistamines
Immunosuppressants
Monoclonal Antibodies (mAbs)
Other Products
6.2. Global Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
German Shepherd
Terriers
Retrievers
Other Dog Breeds
6.3. Global Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ectoparasites
Food Allergy
Allergic Skin Infections
Other Indications
6.4. Global Canine Atopic Dermatitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Injectable
6.5. Global Canine Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Clinics
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.6. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prednisone
Prednisolone
Dexamethasone
Methylprednisolone
Hydrocortisone
Triamcinolone
6.7. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diphenhydramine
Hydroxyzine
Cetirizine
Loratadine
Chlorpheniramine
6.8. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cyclosporine
Tacrolimus
Azathioprine
Mycophenolate Mofetil
6.9. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lokivetmab
Investigational Monoclonal Antibodies
6.10. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Essential Fatty Acid Supplements
Medicated Shampoos And Sprays
Allergen-Specific Immunotherapy (ASIT)
Skin Barrier Repair Creams
Nutraceuticals And Probiotics
7. Canine Atopic Dermatitis Market Regional And Country Analysis
7.1. Global Canine Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Canine Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
